Azidobenzaldehydes are a popular class of azidoaldehydes that have been recognized as
readily available, highly stable, commercially accessible starting materials. Owing to the …

Abstract A series of 1, 2, 3-triazole compounds derived from a salicylaldehyde moiety were
synthesized in high yields using copper (I)-catalyzed azide-alkyne cycloaddition (CuAAC) …

Effective therapy of Alzheimer's disease (AD) requires treatment with a combination of drugs
that modulate various pathomechanisms contributing to the disease. In our research, we …

Development of glycogen synthase kinase-3β (GSK-3β) inactivation-centric agents with
polypharmacological profiles is increasingly recognized as a promising therapeutic strategy …

triazoles are pharmaceutically significant compounds that have attracted recent interest from
medicinal chemists because of their important biological activities. Addressed herein, some …

In this work, we present a simple way to achieve 4-arylselanyl-1 H-1, 2, 3-triazoles from
selenium-containing carbinols in a one-pot strategy. The selenium-containing carbinols …

Herein, we described a simple and efficient protocol for the synthesis of α‐
hydroxyphosphonates containing 1, 2, 3‐triazole moiety in their structures under mild …

Reactions between enamine analogues and terminal alkynes were explored. Copper (I)
complex of 1, 10‐phenanthroline catalyzed these reactions to generate a diastereoselective …

We describe our results for the synthesis of 2′-(1, 2, 3-triazoyl)-acetophenones by copper
catalyzed azide–alkyne cycloaddition of 2′-azidoacetophenone with alkynes. The …

Alzheimer's disease (AD) is an intricate neurological disorder in which degeneration of brain
cells occurs. A recent study has demonstrated that around thirty-six million people are …